Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
143 hedge funds and large institutions have $651M invested in Immunogen Inc in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 26 closing their positions.
186% more call options, than puts
Call options by funds: $5.14M | Put options by funds: $1.8M
59% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 34
6% less funds holding
Funds holding: 152 → 143 (-9)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
38% less capital invested
Capital invested by funds: $1.05B → $651M (-$402M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.74M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$2.07M |
| 3 |
NC
Nexthera Capital
New York
|
+$1.93M |
| 4 |
ClearBridge Investments
New York
|
+$1.88M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.76M |
| 2 |
D.E. Shaw & Co
New York
|
-$4.52M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$2.78M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.36M |
| 5 |
CIP
Convergence Investment Partners
Palm Beach Gardens,
Florida
|
-$1.9M |
IMGN Hedge Fund Activity: Q1 2016 in Review
143 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2016, worth a combined $651M — down 38% from $1.05B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of IMGN and 19 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 54 added.
The largest buyer was Vanguard Group, adding an estimated $2.74M. The largest seller was Fidelity Investments, cutting an estimated $4.76M.
- 143 institutional investors held Immunogen Inc (IMGN) as of Q1 2016, down from 152 in Q4 2015.
- Funds reported $651M of Immunogen Inc stock for Q1 2016, down 38% quarter-over-quarter.
- 19 funds opened new Immunogen Inc positions in Q1 2016 and 26 closed out, a net change of -7 holders.
- The largest Immunogen Inc buyer in Q1 2016 was Vanguard Group, an estimated $2.74M added.
- The largest Immunogen Inc seller in Q1 2016 was Fidelity Investments, an estimated $4.76M sold.
Based on aggregated 13F filings for Q1 2016.